FibroBiologics Inc. (NASDAQ: FBLG) announced preclinical results showing that human dermal fibroblast spheroids reduced inflammation and scarring markers in burn ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE